-
The program for the 2nd edition of the Leveraging mRNA Technology Workshop is currently under development and will be announced in due time.
-
To stay updated on the relevant developments, make sure you are signed up for our newsletter.
Leveraging mRNA Technology Workshop - 2nd Edition
What's New
About this Program
The breakthrough of the mRNA platform enabled the development of SARS-CoV-2 vaccines at an unprecedented pace, heralding a new era for the prevention of other infectious diseases. It opened new avenues to rethink long-standing scientific questions, such as vaccines for hepatitis C and HIV, or neglected tropical diseases, in a scalable and affordable manner.
Beyond prophylaxis, mRNA technology holds promise for treating many rare and common clinical indications. One size does not fit all, and several challenges remain towards achieving broad clinical relevance, including effective targeted delivery, optimal expression, and immunological properties.
Leveraging mRNA technology beyond its current clinical applications relies on fostering scientific discussion to catalyze new concepts and cross-disciplinary innovative solutions. To this end, we propose a forum gathering leading experts from academic and industry settings to facilitate focused scientific interchange on niche topics that are the subject of intensive research yet underrepresented at major international meetings.
Starting from this edition, Quarterly Online Editions Include
- mRNA Cancer Vaccines
- Delivery of Antibodies and Other Biologics by mRNA
- mRNA Delivery Systems
- mRNA Vaccines for Respiratory Diseases
- Mechanism of Action of mRNA Vaccines
- mRNA for Gene Editing and Cell-Based Therapy
Program Directors
General Information
- Researchers from the pharmaceutical and biotech industry.
- Provide a focused forum for scientific exchange addressing remaining challenges for the broader clinical application of mRNA technology;
- Provide a platform for the presentation of latest data and innovative solutions;
- Stimulate cross-disciplinary discussion, collaboration, and evolution of new concepts.
- Summarize the latest advancement in mRNA and lipid nanoparticle biotechnology;
- Reflect on the latest advancement in design and pre-clinical evaluations of novel vaccine candidates;
- Describe clinical data supporting the use of mRNA-based vaccines for infectious diseases;
- Comprehend key clinical considerations for the use of mRNA-based therapeutics in different populations and healthcare settings;
- Reflect on prospects and limitations of mRNA-based vaccines for infectious diseases and beyond.
Practical Information
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
The registration page of this program will open soon.
Fees and Conditions
Regular Delegates* |
Industry** |
|
Standard Fee |
€50.00 |
€95.00 |
Discounts |
|
Early-Career Investigators / Academia from RLS WITH ACCEPTED ABSTRACT |
Complimentary Registration |
Early-Career Investigators / Academia from RLS WITHOUT ACCEPTED ABSTRACT |
|
NGO Representatives / Government Representatives (i.e. MOH, NIH, NIAID, etc.) / Advocates |
50% Off Standard Fee |
Members of Endorsing Organization |
Contact the Secretariat |
Representatives of Sponsoring Industry |
Contact the Secretariat |
*Industry representatives may receive a discount based on the level of support provided to the event. For more support and registration information, please contact us at Gigi.Lam@amededu.com.
Important
-
We strongly advise that you register early to ensure your registration.
-
Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.
- Digital workshop pack, including the program;
IMPORTANT:
- No day rate is available
- Payment can only be made by credit card.
- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
- Cancellation 1 month before the workshop date: 50% refund (minus an administration fee)
- Cancellation after 1 month before the workshop date: Unfortunately, no refund will be given
If you are unable to attend the workshop, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate 14 days before the workshop date. A statement (email/letter) of cancellation must be sent to Virology Education.
The program for the 2nd edition of the Leveraging mRNA Technology Workshop is currently under development and will be announced in due time.
If you would like to view the program for the 1st edition of the Leveraging mRNA Technology Workshop, please click here
Starting from this edition, Quarterly Online Editions Include
- mRNA Cancer Vaccines
- Delivery of Antibodies and Other Biologics by mRNA
- mRNA Delivery Systems
- mRNA Vaccines for Respiratory Diseases
- Mechanism of Action of mRNA Vaccines
- mRNA for Gene Editing and Cell-Based Therapy
Abstracts
- The Leveraging mRNA Technology Workshop - 2nd Edition accepts new original data as well as encored abstracts.
-
Abstract submitters are strongly encouraged to use person-first language in their abstracts. View the video tutorial and guidelines here
-
Information regarding the Abstract Category will be provided shortly.
- Background: A concise statement of the issue under investigation or a hypothesis;
- Material and Methods: The experimental methods used (including the statistical analyses employed);
- Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
- Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).
Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.
Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.
We encourage you to use person-first language in your abstract(s). View our guidelines here: https://academicmedicaleducation.com/person-first-language
Program Directors
Organizing Committee
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.
Support Our Initiative
Financial backing to the Leveraging mRNA Technology Workshop - 2nd Edition helps us deliver an impactful meeting experience for the benefit of healthcare professionals, researchers, and community representatives.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause, get in touch with us for a tailored support package by contacting Gi Gi Lam at Gigi.Lam@amededu.com or call +31 30 230 7140.
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.
- Symposium opportunities
- Non-commercial interviews with company representatives
- Verbal acknowledgement during the program
- Discounted and complimentary registrations for your representatives
- Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
- Company acknowledgement on printed meeting materials including but not limited to banners and the program book
- Digital and printed advertising opportunities
- Social media shout-outs
- Logo on the conference bag
*Subject to the support level.
Become an Endorser
If you would like your organization to support the 2nd edition of the Leveraging mRNA Technology Workshop as an endorser or media partner, please contact Ms. Michelle Wu at Michelle.Wu@amededu.com.
Endorsers
The Leveraging mRNA Technology Workshop - 2nd Edition is endorsed by the following organizations:
Group Photo
Please find the Group Photo for the Leveraging mRNA Technology Workshop - 1st Edition below.
Promo Video
Please find the Promo Video for the Leveraging mRNA Technology Workshop - 1st Edition below